Breaking News Instant updates and real-time market news.

FNSR

Finisar

$21.87

0.45 (2.10%)

17:59
09/17/17
09/17
17:59
09/17/17
17:59

Finisar has catalysts to help accelerate growth, says Piper Jaffray

Piper Jaffray analyst Troy Jensen recommends investors revisit Finisar shares as he believes the optical group will likely experience accelerating growth in 2018 and believes Finisar has some company specific catalysts to help accelerate growth. The analyst believes China demand will improve by year-end and into 2018 with inventor levels being reduced and new China tenders helping grow demand. Jensen also believes Finisar will see VCSEL sales start an impressive ramp in October, coupled with initial revenues for the CFP2-ACO qualification at Cisco in the January quarter followed by ROADM line cards in the April quarter. This growth recovery coupled with lowered assumptions and valuation creates an "attractive entry point," he contends. The analyst reiterates an Overweight rating and $26 price target on the shares.

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

FNSR Finisar
$21.87

0.45 (2.10%)

09/08/17
PIPR
09/08/17
NO CHANGE
Target $26
PIPR
Overweight
Finisar outlook disappointing, but demand should improve, says Piper Jaffray
Piper Jaffray analyst Troy Jensen Finisar's July quarter as mixed, with revenue and earnings in-line with expectations while the October quarter guidance came in well below consensus. The analyst believes China demand will start to slowly rebound with excess inventory being worked down. He anticipates a stronger recovery in China during 2018 with 100G metro upgrades likely to begin in the next six months. The analyst lowered his price target for Finisar shares to $26 from $30 and keeps an Overweight rating on the name.
09/08/17
CHLM
09/08/17
NO CHANGE
Target $28
CHLM
Buy
Finisar price target lowered to $28 from $38 at Craig-Hallum
Craig-Hallum analyst Richard Shannon Finisar's Q2 guidance was "quite poor," though he sees temporary factors far offsetting cyclical factors in October and thinks these should reverse in the near-future. The company blamed a manufacturing process tweak for pushing out 3D sensor sales by a quarter, but Shannon does not think this implies lost share with its lead customer, he tells investors. The analyst lowered his price target on Finisar shares to $28 from $38 but keeps his Buy rating on the stock.
09/08/17
MKMP
09/08/17
NO CHANGE
MKMP
Finisar catlysts just 'delayed,' not 'canceled,' says MKM Partners
After Finisar's Q2 guidance came in well below expectations, MKM Partners analyst Michael Genovese says that "all of the meaningful catalysts for the stock are delayed, but none are canceled." He says that "the most important catalyst," 3D Sensing, "is only delayed by one quarter," while two other positive catalysts - "full Verizon qualification and demand recovery in China" - "are delayed by 1-2 quarters." He trimmed his price target on the name to $31 from $33 but keeps a Buy rating on the stock.
09/08/17
NEED
09/08/17
NO CHANGE
NEED
Finisar price target lowered to $34 from $44 at Needham
Needham analyst Alex Henderson lowered his price target on Finisar after the company cut its Q3 guidance. However, he keeps a Strong Buy rating on the stock.

TODAY'S FREE FLY STORIES

TIF

Tiffany

$126.28

0.7 (0.56%)

16:55
09/25/18
09/25
16:55
09/25/18
16:55
Hot Stocks
Tiffany director Fish sells 6,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ABBV

AbbVie

$93.78

0.34 (0.36%)

16:52
09/25/18
09/25
16:52
09/25/18
16:52
Hot Stocks
AbbVie approved for VENCLEXTAR/Rituximab leukemia treatment in Canada »

AbbVie announced Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CONE

CyrusOne

$64.65

-0.6 (-0.92%)

16:51
09/25/18
09/25
16:51
09/25/18
16:51
Syndicate
CyrusOne 8M share Spot Secondary; price range $62.00-$64.00 »

Morgan Stanley, Deutsche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

CHGG

Chegg

$32.34

0.92 (2.93%)

16:50
09/25/18
09/25
16:50
09/25/18
16:50
Hot Stocks
Chegg says unauthorized party gained access to a company database »

On September 19, Chegg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

EGY

VAALCO Energy

$2.59

0.14 (5.71%)

16:47
09/25/18
09/25
16:47
09/25/18
16:47
Hot Stocks
VAALCO Energy announces 10-year extension of Etame exploration area »

VAALCO Energ through its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$27.86

-0.05 (-0.18%)

16:40
09/25/18
09/25
16:40
09/25/18
16:40
Options
Calls lead puts 30:1 in MGM as long call position is adjusted »

Calls lead puts 30:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

NNI

Nelnet

$56.82

-0.79 (-1.37%)

16:38
09/25/18
09/25
16:38
09/25/18
16:38
Hot Stocks
Nelnet withdraws application for industrial bank charter with FDIC »

Nelnet announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
09/25/18
09/25
16:38
09/25/18
16:38
General news
API crude inventories for week of September 21 »

API reports that crude…

IGT

International Game

$19.91

0.23 (1.17%)

16:37
09/25/18
09/25
16:37
09/25/18
16:37
Hot Stocks
International Game partners with William Hill on U.S. lotteries »

IGT Global Solutions, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$26.45

0.15 (0.57%)

16:34
09/25/18
09/25
16:34
09/25/18
16:34
Hot Stocks
Scientific Games signs contract with Hard Rock International »

Scientific Games…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGLY

Digital Ally

$3.75

-0.275 (-6.83%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Syndicate
Digital Ally files to sell common stock, no amount given »

Roth Capital Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

R

Ryder

$72.75

-0.04 (-0.05%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Ryder CFO Art Garcia to retire in April 2019 »

Ryder announced that Art…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BZH

Beazer Homes

$11.08

-0.015 (-0.14%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Beazer says Hurricane Florence will result in sales, closings shifting to FY19 »

Beazer Homes provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$172.88

-2.66 (-1.52%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Moody's appoints Mona Breed as CIO »

Moody's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 21

    Oct

FCFS

First Cash Financial

$83.03

0.625 (0.76%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
First Cash Financial announces move to Nasdaq from NYSE »

FirstCash announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 06

    Nov

OKE

Oneok

$68.44

0.565 (0.83%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Oneok to construct additional NGL fractionation, pipeline capacity »

Oneok announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/25/18
09/25
16:30
09/25/18
16:30
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

MOR

MorphoSys

$27.13

0.315 (1.17%)

16:28
09/25/18
09/25
16:28
09/25/18
16:28
Hot Stocks
MorphoSys says licensee has begun study to test gselkumab in pediatric group »

MorphoSys announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:26
09/25/18
09/25
16:26
09/25/18
16:26
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Jefferies, Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:24
09/25/18
09/25
16:24
09/25/18
16:24
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:23
09/25/18
09/25
16:23
09/25/18
16:23
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Verastem rises over 5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell looks to bring mastitis treatment to market in 2020 »

ImmuCell announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell receives fourth complete letter of NADA for Nisin treatment for cows »

Immucell announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Verastem and CSPC Pharma sign license agreement to develop COPIKTRA in China »

Verastem and CSPC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

LOXO

Loxo Oncology

$166.80

3.73 (2.29%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Loxo Oncology announces LOXO-292 durability update »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.